Lymphomas: The Role of CT and MRI in Staging and Restaging

  • Vassilis C. KoutoulidisEmail author


Please check if the affiliation is presented correctly.


  1. 1.
    Matasar MJ, Zelenetz AD (2008) Overview of lymphoma diagnosis and management. Radiol Clin N Am 46(2):175–198CrossRefGoogle Scholar
  2. 2.
    Kwee TC, Kwee RM, Nievelstein RA (2008) Imaging in staging of malignant lymphoma: a systematic review. Blood 111(2):504–516CrossRefGoogle Scholar
  3. 3.
    Cronin CG, Swords R, Truong MT et al (2010) Clinical utility of PET/CT in lymphoma. AJR 194(1):W91–W103CrossRefGoogle Scholar
  4. 4.
    Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7(11):1630–1636CrossRefGoogle Scholar
  5. 5.
    American Joint Committee on Cancer (2010) Lymphoid neoplasms. In: AJCC cancer staging manual, 7th edn. Springer, New York, pp 599–615CrossRefGoogle Scholar
  6. 6.
    Aiken AH, Glastonbury C (2008) Imaging Hodgkin and non-Hodgkin lymphoma in the head and neck. Radiol Clin N Am 46(2):363–378CrossRefGoogle Scholar
  7. 7.
    Bae YA, Lee KS (2008) Cross-sectional evaluation of thoracic lymphoma. Radiol Clin North Am 46(2):253–264CrossRefGoogle Scholar
  8. 8.
    Schwartz LH, Bogaerts J, Ford R et al (2009) Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer 45(2):261–267CrossRefGoogle Scholar
  9. 9.
    Hricak H, Husband J, Panicek DM (2009) Essentials of reporting common cancers in: oncologic imaging. Saunders Elsevier, Philadelphia, p 12Google Scholar
  10. 10.
    de Jong PA, van Ufford HM, Baarslag HJ et al (2009) CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR 192(3):745–753CrossRefGoogle Scholar
  11. 11.
    Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29(14):1844–1854CrossRefGoogle Scholar
  12. 12.
    Seam P, Juweid ME, Cheson BD (2007) The role of FDG-PET scans in patients with lymphoma. Blood 110(10):3507–3516CrossRefGoogle Scholar
  13. 13.
    Cheson BD (2009) The case against heavy PETing. J Clin Oncol 27(11):1742–1743CrossRefGoogle Scholar
  14. 14.
    Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. J Clin Oncol 17(4):1244–1253CrossRefGoogle Scholar
  15. 15.
    Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging Subcommittee of International harmonization project in lymphoma. J Clin Oncol 25(5):571–578CrossRefGoogle Scholar
  16. 16.
    Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579–586CrossRefGoogle Scholar
  17. 17.
    Vermoolen MA, Kersten MJ, Fijnheer R et al (2011) Magnetic resonance imaging of malignant lymphoma. Expert Rev Hematol 4(2):161–171CrossRefGoogle Scholar
  18. 18.
    Punwani S, Taylor SA, Bainbridge A et al (2010) Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology 255(1):182–190CrossRefGoogle Scholar
  19. 19.
    Brennan DD, Gleeson T, Coate LE et al (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. AJR 185(3):711–716CrossRefGoogle Scholar
  20. 20.
    Gu J, Chan T, Zhang J et al (2011) Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR 197(3):W384–W391CrossRefGoogle Scholar
  21. 21.
    Abrey LE, Batchelor TT, Ferreri AJ et al (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23(22):5034–5043CrossRefGoogle Scholar
  22. 22.
    Slone HW, Blake JJ, Shah R et al (2005) CT and MRI findings of intracranial lymphoma. AJR 184(5):1679–1685CrossRefGoogle Scholar
  23. 23.
    Guo AC, Cummings TJ, Dash RC et al (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224(1):177–183CrossRefGoogle Scholar
  24. 24.
    Mohile NA, Deangelis LM, Abrey LE (2008) The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro-Oncology 10(2):223–228CrossRefGoogle Scholar
  25. 25.
    Pels H, Juergens A, Schirgens I et al (2010) Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma. Neuro-Oncology 12(7):720–724CrossRefGoogle Scholar
  26. 26.
    Littooij AS, Kwee TC, Barber I et al (2014) Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard. Eur Radiol 24(5):1153–1165CrossRefGoogle Scholar
  27. 27.
    Kwee TC, Vermoolen MA, Akkerman EA et al (2014) Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study. J Magn Reson Imaging 40(1):26–36CrossRefGoogle Scholar
  28. 28.
    Mayerhoefer ME, Karanikas G, Kletter K et al (2014) Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients. Clin Cancer Res 20(11):2984–2993CrossRefGoogle Scholar
  29. 29.
    Horger M, Claussen C, Kramer U et al (2014) Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity – a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging. Eur J Radiol 83(9):1655–1664CrossRefGoogle Scholar
  30. 30.
    De Paepe K, Bevernage C, De Keyzer F et al (2013) Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study. Cancer Imaging 13(1):53–62CrossRefGoogle Scholar
  31. 31.
    Littooij AS, Kwee TC, de Keizer B et al (2015) Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: a prospective multicenter study. J Magn Reson Imaging 42(6):1646–1655CrossRefGoogle Scholar
  32. 32.
    Siegel MJ, Jokerst CE, Rajderkar D et al (2014) Diffusion-weighted MRI for staging and evaluation of response in diffuse large B-cell lymphoma: a pilot study. NMR Biomed 27(6):681–691CrossRefGoogle Scholar
  33. 33.
    Sun M, Cheng J, Zhang Y et al (2016) Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma. J Magn Reson Imaging 44(6):1522–1529CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiology, Areteion HospitalNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations